International Stem Cell extends CEO's $2.7M loan maturity to Sept 2025 after repaying $200k

International Stem Cell CORP

CEO Dr. Andrey Semechkin loan of $2.9M extended; $200k repaid, new $2.7M unsecured note issued.
New note bears 5.5% interest, matures Sept 15, 2025, prepayable without penalty.
Accrued unpaid interest of ~$645k from prior note remains outstanding.
Related-party transaction creates direct financial obligation; Noteholder is Co-Chairman and CEO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.